Articles tagged "Kidney/liver transplantation"

2019 American Transplant Congress
Use of a CMV Specific T Cell Immunity Assay in Late-Onset CMV Infection
O. Beaird¹, M. Carlson¹, P. Gaynor¹, D. Nanayakkara¹, B. Abdalla², S. Bunnapradist², J. Schaenman¹
¹Department of Internal Medicine - Division Infectious Diseases, UCLA, Los Angeles, CA, ²Department of Internal Medicine - Division Nephrology, UCLA, Los Angeles, CA
*Purpose: To describe our clinical experience using a CMV Specific Cell Mediated Immunity (CMI) assay in solid organ transplant (SOT) recipients with late-onset CMV, defined…
2019 American Transplant Congress
Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients
K. Ostendorf¹, N. Memaran¹, B. Borchert-Mörlins¹, J. von der Born¹, E. Bauer¹, A. von Wick¹, J. Oh², M. J. Kemper³, R. Büscher⁴, B. M. Schmidt⁵, A. Melk¹
¹Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany, ²Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, ³Department of Pediatrics, Asklepios Klinik Nord - Heidberg, Hamburg, Germany, ⁴Pediatric Nephrology, University Hospital, Essen, Germany, ⁵Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
*Purpose: The second most common cause of death in pediatric kidney transplant (KT) recipients are cardiovascular (CV) diseases. We have previously shown that pulse wave…
2019 American Transplant Congress
Rapid Growth of HCV-Infected Donors for HCV-Uninfected Kidney and Liver Transplant Recipients in the United States
M. Bowring, A. Shaffer, A. Massie, N. Desai, M. Sulkowski, A. Cameron, J. Garonzik-Wang, D. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: Several single-center reports of using HCV-viremic organs for HCV-uninfected recipients were recently published in the US. In light of recent DAA introduction, we sought…
2019 American Transplant Congress
Letermovir for CMV Treatment in Solid Organ Transplant
O. Witkowsky, M. Chunduru, A. Chung, A. Diez
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Letermovir (LET), a novel anti-CMV agent, was recently approved for CMV prophylaxis in stem cell transplant recipients and is currently under investigation as a…
2019 American Transplant Congress
Low Specific Gravity Of First Morning Urine Predicts Bkvn in Kidney Transplant Recipients With Bk Viruria
G. Huang¹, X. Chen¹, Z. Wang², Y. Nuertai², W. Chen³, S. Yang³, P. Chen⁴, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Clinical Medicine, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, China, ³Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ⁴Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: BK Polyomavirus nephropathy (BKVN) is an important cause of dysfunction and failure of renal transplants. BKV usually infects urinary tract retrogradely. The collecting duct…
2019 American Transplant Congress
BTLA Suppressed Acute Rejection by Regulating T Cell Receptor Downstream Signal Pathways and Cytokine Production in Renal Transplant and Contributed to Prolongation of Allograft Survival
J. Zhang, Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: The present study aimed to investigate the role of BTLA in the progress of acute rejection after kidney transplantation.*Methods: In human allograft renal transplanted…
2019 American Transplant Congress
Evaluation of Pneumocystis jirovecii Pneumonia Prophylaxis among Kidney and Liver Transplant Recipients; Trimethoprim/Sulfamethoxazole vs Alternative Therapies
E. Aldag, C. Pagels, R. Pedersen, I. Nadeem, V. Gunabushanam, A. Sahajpal, T. J. Dilworth
Aurora St Luke's Medical Center, Milwaukee, WI
*Purpose: To describe Pneumocystis Jirovecii Pneumonia (PJP) prophylaxis (ppx) practices in our transplant recipients and to determine its safety and efficacy.*Methods: Retrospective review of kidney…
2019 American Transplant Congress
The Use of Mobile Software for Real-Time, Secure, Team-Based Procurement and Transplantation Team Communication to Improve the Deceased Donor Organ Transplantation Process
E. Pahl
HealthTech Solutions, Inc., Coralville, IA
*Purpose: Deceased donor organ (DDO) transplantation is an effective cure for patients suffering from organ failure. Organ transplantation is cost-effective, provides a significant survival benefit,…
2019 American Transplant Congress
Delayed Kidney Transplantation in Combined Liver Kidney Transplantation: A Validation Analysis by the UNOS Registry
L. Chau, M. Safwan, M. Rizzari, K. Collins, A. Yoshida, M. Abouljoud, D. Moonka, S. Nagai
Transplant Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Delayed kidney transplantation for patients undergoing combined liver-kidney transplant (CLKT) have been suggested to improve patient survival and kidney function compared to simultaneous liver-kidney…
2019 American Transplant Congress
Iguratimod Attenuates the Production of Donor Specific Antibody by Inducing CD19⁺Tim-1⁺ Regulatory B Cells and Imbalance of Th17 Treg
Z. Wang, S. Fei, H. Chen, Z. Han, L. Sun, J. Tao, X. Ju, M. Zheng, R. Tan, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: This study was designed to investigate the effect and mechanisms of Iguratimod on circulating DSA and allograft survival in a skin transplant model.*Methods: Mice…